Additional file 3 of Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma

Abstract

Additional file 3: Supplementary Figure 1. (A) The best-fit OS-related lncRNAs were chosen by Lasso regression analysis. (B) The Lasso regression was performed with the optimal value of λ. (C-D) Distribution of risk scores, survival status. Supplementary Figure 2. (A-D) PCA among all genes, immune genes, immune LncRNA, and risk immune LncRNA